Lynx Therapeutics Stands to Gain $300,000 in Stock-Purchase Warrant Placed With Lender | GenomeWeb

This article corrects an earlier version that reported that Lynx had sold $300,000 worth of shares to Silicon Valley Bank. In fact, the company issued a warrant for the bank to buy the stock.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.